A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid

被引:112
|
作者
Ito, Yasuhiro [1 ]
Miyauchi, Akira [1 ]
机构
[1] Kuma Hosp, Dept Surg, Chuo Ku, Kobe, Hyogo 6500011, Japan
关键词
microcarcinoma; observation; papillary prognosis; surgery; thyroid;
D O I
10.1038/ncpendmet0428
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Papillary microcarcinoma of the thyroid (PMCT) is defined as papillary carcinoma measuring 1.0 cm or less. PCMT are frequently detected by ultrasonographic screening and ultrasonography-guided fine-needle aspiration biopsy. Although PMCT can pathologically show a high incidence of multifocality and lymph node metastasis in surgical specimens, most tumors grow slowly or not at all when they are monitored without surgery. In our observations only 6.7% of PMCT enlarged by 3.0 mm or more in diameter during 5 years of follow-up, and nodal metastases became detectable in 1.7% of patients overall. Observation without surgery could, therefore, be an attractive alternative for patients with low-risk PMCT; however, occult PMCT, which are diagnosed as the origin of lymph node or distant metastasis, show a worse prognosis. Even among incidentally detected PMCT, tumors with ultrasonographically detectable nodal metastasis are more likely to recur. Because such PMCT are most likely to recur in the regional lymph nodes, careful therapeutic neck dissection and total thyroidectomy are required. For incidentally detected and low-risk PMCT, careful observation without surgery might be acceptable, but careful and systematic surgery should be performed for patients with PMCT demonstrating aggressive characteristics.
引用
收藏
页码:240 / 248
页数:9
相关论文
共 50 条
  • [31] Frequent RET rearrangements in thyroid papillary microcarcinoma detected by interphase fluorescence in situ hybridization
    Corvi, R
    Martinez-Alfaro, M
    Harach, HR
    Zini, M
    Papotti, M
    Romeo, G
    LABORATORY INVESTIGATION, 2001, 81 (12) : 1639 - 1645
  • [32] The overtreatment of papillary thyroid microcarcinoma in the community
    Abraham, Peter J.
    Wu, Christopher
    Wang, Rongzhi
    Herring, Brendon
    Zmijewski, Polina
    Gillis, Andrea
    Fazendin, Jessica
    Lindeman, Brenessa
    Chen, Herbert
    AMERICAN JOURNAL OF SURGERY, 2024, 233 : 132 - 135
  • [33] Multifocality and Bilaterality of Papillary Thyroid Microcarcinoma
    So, Yoon Kyoung
    Kim, Myung Woo
    Son, Young-Ik
    CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY, 2015, 8 (02) : 174 - 178
  • [34] PAPILLARY MICROCARCINOMA OF THE THYROID-GLAND
    SOLIMAN, T
    WIENER KLINISCHE WOCHENSCHRIFT, 1993, 105 (20) : 591 - 594
  • [35] Active surveillance in papillary thyroid microcarcinoma
    Lamartina, L.
    Leboulleux, S.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2019, 23 (4-5): : 116 - 118
  • [36] Papillary thyroid microcarcinoma: Retrospective study
    Rodrigues, P.
    Costa, F.
    Martins, M. J.
    VIRCHOWS ARCHIV, 2017, 471 : S69 - S69
  • [37] Incidental and nonincidental papillary thyroid microcarcinoma
    Lin, Jen-Der
    Kuo, Sheng-Fong
    Chao, Tzu-Chieh
    Hsueh, Chuen
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (08) : 2287 - 2292
  • [38] Papillary thyroid microcarcinoma in struma ovarii
    Meringolo, Domenico
    Bianchi, Davide
    Capula, Carmelo
    Costante, Giuseppe
    ENDOCRINE, 2012, 41 (01) : 164 - 165
  • [39] Parathyromatosis coexisting with papillary thyroid microcarcinoma
    Diaconescu, M. R.
    Glod, M.
    Grigorovici, M.
    Diaconescu, S.
    CHIRURGIA, 2011, 106 (05) : 669 - 672
  • [40] Overtherapy or undertherapy for papillary thyroid microcarcinoma?
    Dietlein, M
    Schober, O
    Schicha, H
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2004, 43 (04): : 107 - 114